[1] Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, et al. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS. 2005;113(11-12): 876-902.
[2] Dollé L, Best J, Mei J, et al. The quest for liver progenitor cells: a practical point of view. J Hepatol. 2010;52(1):117-129.
[3] Pareja E, Gomez-Lechon MJ, Cortes M, et al. Human hepatocyte transplantation in patients with hepatic failure awaiting a graft. Eur Surg Res. 2013;50(3-4):273-281.
[4] Wang F, Zhou L, Ma X, et al. Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure: a prospective five-year follow-up study. Transplant Proc. 2014; 46(1):192-198.
[5] Mazariegos G, Shneider B, Burton B, et al. Liver transplantation for pediatric metabolic disease. Mol Genet Metab. 2014;111(4):418-427.
[6] Biancofiore G, Davis CL. Renal dysfunction in the perioperative liver transplant period. Curr Opin Organ Transplant. 2008;13(3):291-297.
[7] Mukherjee S, Botha JF, Mukherjee U. Immunosuppression in liver transplantation. Curr Drug Targets. 2009;10(6):557-574.
[8] Timm F, Vollmar B. Heterogeneity of the intrahepatic portal venous blood flow: impact on hepatocyte transplantation. Microvasc Res. 2013;86:34-41.
[9] Stutchfield BM, Forbes SJ, Wigmore SJ. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 2010;16(7):827-836.
[10] Katoonizadeh A, Nevens F, Verslype C, et al. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int. 2006;26(10): 1225-1233.
[11] Saxena R, Theise N. Canals of Hering: recent insights and current knowledge. Semin Liver Dis. 2004;24(1):43-48.
[12] Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39(6): 1477-1487.
[13] Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43(2 Suppl 1):S45-53.
[14] Roskams T, De Vos R, Van Eyken P, et al. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol. 1998;29(3):455-463.
[15] Fujita M, Furukawa H, Hattori M, et al. Sequential observation of liver cell regeneration after massive hepatic necrosis in auxiliary partial orthotopic liver transplantation. Mod Pathol. 2000;13(2):152-157.
[16] Lowes KN, Brennan BA, Yeoh GC, et al. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol. 1999;154(2):537-541.
[17] Ray MB, Mendenhall CL, French SW, et al. Bile duct changes in alcoholic liver disease. The Veterans Administration Cooperative Study Group. Liver. 1993;13(1):36-45.
[18] Libbrecht L, Desmet V, Van Damme B, et al. Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate. J Pathol. 2000;192(3):373-378.
[19] Desmet V, Roskams T, Van Eyken P. Ductular reaction in the liver. Pathol Res Pract. 1995;191(6):513-524.
[20] Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl. 2001;7(10):835-844.
[21] Parola M, Pinzani M. Hepatic wound repair. Fibrogenesis Tissue Repair. 2009;2(1):4.
[22] Ghavami S, Hashemi M, Kadkhoda K, et al. Apoptosis in liver diseases--detection and therapeutic applications. Med Sci Monit. 2005;11(11):RA337-345.
[23] Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology. 2009;137(2):466-481.
[24] Fellous TG, Islam S, Tadrous PJ, et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology. 2009;49(5):1655-1663.
[25] Campbell JS, Prichard L, Schaper F, et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest. 2001;107(10):1285-1292.
[26] Jung Y, Oh SH, Witek RP, et al. Somatostatin stimulates the migration of hepatic oval cells in the injured rat liver. Liver Int. 2012;32(2):312-320.
[27] Nobili V, Carpino G, Alisi A, et al. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology. 2012;56(6): 2142-2153.
[28] Lozoya OA, Wauthier E, Turner RA, et al. Regulation of hepatic stem/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche. Biomaterials. 2011;32(30):7389-7402.
[29] Kallis YN, Robson AJ, Fallowfield JA, et al. Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut. 2011;60(4):525-533.
[30] Ruddell RG, Knight B, Tirnitz-Parker JE, et al. Lymphotoxin- beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Hepatology. 2009;49(1):227-239.
[31] Subrata LS, Voon DC, Yeoh GC, et al. TNF-inducible expression of lymphotoxin-β in hepatic cells: an essential role for NF-κB and Ets1 transcription factors. Cytokine. 2012;60(2): 498-4504.
[32] Kuramitsu K, Sverdlov DY, Liu SB, et al. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol. 2013; 183(1):182-194.
[33] Dwyer BJ, Olynyk JK, Ramm GA, et al. TWEAK and LTβ Signaling during Chronic Liver Disease. Front Immunol. 2014; 5:39.
[34] Dechêne A, Sowa JP, Gieseler RK, et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology. 2010;52(3):1008-1016.
[35] Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17: 387-403.
[36] Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441(7097): 1068-1074.
[37] Best J, Dollé L, Manka P, et al. Role of liver progenitors in acute liver injury. Front Physiol. 2013;4:258.
[38] Russo FP, Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy. 2011;13(2):135-144.
[39] Maitra A, Arking DE, Shivapurkar N, et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet. 2005;37(10):1099-1103.
[40] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676.
[41] Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917-1920.
[42] Okita K, Nagata N, Yamanaka S. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212-215.
[43] Dollé L, Best J, Empsen C, et al. Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve mice. Hepatology. 2012;55(2):540-552.
[44] Hao PP, Lee MJ, Yu GR, et al. Isolation of EpCAM(+)/CD133 (-) hepatic progenitor cells. Mol Cells. 2013;36(5):424-431.
[45] Yovchev MI, Dabeva MD, Oertel M. Isolation, characterization, and transplantation of adult liver progenitor cells. Methods Mol Biol. 2013;976:37-51.
[46] Yasui O, Miura N, Terada K, et al. Isolation of oval cells from Long-Evans Cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology. 1997;25(2): 329-334.
[47] Cardinale V, Wang Y, Carpino G, et al. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets. Hepatology. 2011;54(6):2159-2172.
[48] Oikawa T, Kamiya A, Zeniya M, et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology. 2013;57(4):1469-1483.
[49] Stachelscheid H, Urbaniak T, Ring A, et al. Isolation and characterization of adult human liver progenitors from ischemic liver tissue derived from therapeutic hepatectomies. Tissue Eng Part A. 2009;15(7):1633-1643.
[50] Gerlach JC, Over P, Turner ME, et al. Perivascular mesenchymal progenitors in human fetal and adult liver. Stem Cells Dev. 2012;21(18):3258-3269.
[51] Crisan M, Corselli M, Chen CW, et al. Multilineage stem cells in the adult: a perivascular legacy. Organogenesis. 2011;7(2): 101-104.
[52] Cordeiro-Spinetti E, de Mello W, Trindade LS, et al. Human bone marrow mesenchymal progenitors: perspectives on an optimized in vitro manipulation. Front Cell Dev Biol. 2014;2:7.
[53] Baer PC. Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro. World J Stem Cells. 2014;6(3):256-265. |